Aarkstore Enterprise-Oil and Gas Storage Industry to 2015 - Cost Reduction
9 views | +0 today
Follow
Aarkstore Enterprise-Oil and Gas Storage Industry to 2015 - Cost Reduction
Company, a leading business intelligence provider, has released its latest research, ”Oil and Gas Storage Industry to 2015 - Cost Reduction Strategies in the Form of Storage Facility Sharing to Boost the Market”.
Curated by Aarkstore.com
Your new post is loading...
Your new post is loading...
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Yellow Fever – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Yellow Fever – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore Enterprise-Oil and Gas Storage Industry to 2015 - Cost Reduction | Scoop.it

Global Markets Direct’s, Yellow Fever - Pipeline Review, H1 2012, provides an
overview of the Yellow Fever therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Yellow Fever – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Yellow-Fever-Pipeline-Review-H1-2012-215258.html

RSS link of Global Markets Direct 
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Yellow Fever - Pipeline Review, H1 2012, provides an overview of the Yellow Fever therapeutic pipeline. This report provides information on the therapeutic development for Yellow Fever, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Yellow Fever. Yellow Fever - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Yellow Fever.
- A review of the Yellow Fever products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Yellow Fever Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Yellow Fever 7
Yellow Fever Therapeutics under Development by Companies 9
Yellow Fever Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Yellow Fever Therapeutics – Products under Development by Companies 14
Yellow Fever Therapeutics – Products under Investigation by Universities/Institutes 15
Companies Involved in Yellow Fever Therapeutics Development 16
Alfacell Corporation 16
Crucell N.V. 17
iBio, Inc. 18
Xcellerex, Inc. 19
Yellow Fever – Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
Flavimun - Drug Profile 25
Product Description 25
Mechanism of Action 25

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012

Kawasaki Disease – Pipeline Review, H1 2012

Retinopathy – Pipeline Review, H1 2012

Patent Ductus Arteriosus – Pipeline Review, H1 2012

Yellow Fever – Pipeline Review, H1 2012

Cat Allergy – Pipeline Review, H1 2012

Lymphangioleiomyomatosis – Pipeline Review, H1 2012

Cholera – Pipeline Review, H1 2012

NeuroVive Pharmaceutical AB – Product Pipeline Review – 2012

Abiogen Pharma S.p.A. – Product Pipeline Review – 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Retinopathy – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Retinopathy – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore Enterprise-Oil and Gas Storage Industry to 2015 - Cost Reduction | Scoop.it

Global Markets Direct’s, Retinopathy - Pipeline Review, H1 2012, provides an
overview of the Retinopathy therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Retinopathy – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Retinopathy-Pipeline-Review-H1-2012-215256.html

RSS link of Global Markets Direct 
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Retinopathy - Pipeline Review, H1 2012, provides an overview of the Retinopathy therapeutic pipeline. This report provides information on the therapeutic development for Retinopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Retinopathy. Retinopathy - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Retinopathy.
- A review of the Retinopathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Retinopathy Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Retinopathy 8
Retinopathy Therapeutics under Development by Companies 10
Retinopathy Therapeutics under Investigation by Universities/Institutes 12
Late Stage Products 14
Comparative Analysis 14
Mid Clinical Stage Products 15
Comparative Analysis 15
Early Clinical Stage Products 16
Comparative Analysis 16
Discovery and Pre-Clinical Stage Products 17
Comparative Analysis 17
Retinopathy Therapeutics – Products under Development by Companies 18
Retinopathy Therapeutics – Products under Investigation by Universities/Institutes 19
Companies Involved in Retinopathy Therapeutics Development 20
NsGene A/S 20
Compugen Ltd. 21
Acucela Inc. 22
Gene Signal International SA. 23
Indus Biotech Private Limited 24
Affichem 25
Resolvyx Pharmaceuticals, Inc 26
SIFI Pharma 27
EyeGene, Inc. 28
Retinopathy – Therapeutics Assessment 29
Assessment by Monotherapy Products 29

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012

Kawasaki Disease – Pipeline Review, H1 2012

Retinopathy – Pipeline Review, H1 2012

Patent Ductus Arteriosus – Pipeline Review, H1 2012

Yellow Fever – Pipeline Review, H1 2012

Cat Allergy – Pipeline Review, H1 2012

Lymphangioleiomyomatosis – Pipeline Review, H1 2012

Cholera – Pipeline Review, H1 2012

NeuroVive Pharmaceutical AB – Product Pipeline Review – 2012

Abiogen Pharma S.p.A. – Product Pipeline Review – 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1



You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals ||Bacterial (Pyogenic) Meningitis – Pipeline Review || Aarkstore.com

2012 || Pharmaceuticals ||Bacterial (Pyogenic) Meningitis – Pipeline Review || Aarkstore.com | Aarkstore Enterprise-Oil and Gas Storage Industry to 2015 - Cost Reduction | Scoop.it

Global Markets Direct’s, Bacterial (Pyogenic) Meningitis - Pipeline Review, H1
2012, provides an overview of the Bacterial (Pyogenic) Meningitis therapeutic
pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Bacterial-Pyogenic-Meningitis-Pipeline-Review-H1-2012-215254.html

RSS link of Global Markets Direct 
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Bacterial (Pyogenic) Meningitis - Pipeline Review, H1 2012, provides an overview of the Bacterial (Pyogenic) Meningitis therapeutic pipeline. This report provides information on the therapeutic development for Bacterial (Pyogenic) Meningitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bacterial (Pyogenic) Meningitis. Bacterial (Pyogenic) Meningitis - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Bacterial (Pyogenic) Meningitis.
- A review of the Bacterial (Pyogenic) Meningitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Bacterial (Pyogenic) Meningitis Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Bacterial (Pyogenic) Meningitis 8
Bacterial (Pyogenic) Meningitis Therapeutics under Development by Companies 10
Bacterial (Pyogenic) Meningitis Therapeutics under Investigation by Universities/Institutes 11
Late Stage Products 12
Comparative Analysis 12
Mid Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
Bacterial (Pyogenic) Meningitis Therapeutics – Products under Development by Companies 15
Bacterial (Pyogenic) Meningitis Therapeutics – Products under Investigation by Universities/Institutes 16
Companies Involved in Bacterial (Pyogenic) Meningitis Therapeutics Development 17
Baxter International Inc. 17
Novartis AG 18
Pfizer Inc. 19
GlycoVaxyn AG 20
Sinovac Biotech Ltd. 21
Bacterial (Pyogenic) Meningitis – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Combination Products 23


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012

Kawasaki Disease – Pipeline Review, H1 2012

Retinopathy – Pipeline Review, H1 2012

Patent Ductus Arteriosus – Pipeline Review, H1 2012

Yellow Fever – Pipeline Review, H1 2012

Cat Allergy – Pipeline Review, H1 2012

Lymphangioleiomyomatosis – Pipeline Review, H1 2012

Cholera – Pipeline Review, H1 2012

NeuroVive Pharmaceutical AB – Product Pipeline Review – 2012

Abiogen Pharma S.p.A. – Product Pipeline Review – 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Patent Ductus Arteriosus – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Patent Ductus Arteriosus – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore Enterprise-Oil and Gas Storage Industry to 2015 - Cost Reduction | Scoop.it

Global Markets Direct’s, Patent Ductus Arteriosus - Pipeline Review, H1 2012,
provides an overview of the Patent Ductus Arteriosus therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Patent Ductus Arteriosus – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Patent-Ductus-Arteriosus-Pipeline-Review-H1-2012-215257.html


RSS link of Global Markets Direct 
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Patent Ductus Arteriosus - Pipeline Review, H1 2012, provides an overview of the Patent Ductus Arteriosus therapeutic pipeline. This report provides information on the therapeutic development for Patent Ductus Arteriosus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Patent Ductus Arteriosus. Patent Ductus Arteriosus - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Patent Ductus Arteriosus.
- A review of the Patent Ductus Arteriosus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Patent Ductus Arteriosus Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Patent Ductus Arteriosus 7
Patent Ductus Arteriosus Therapeutics under Development by Companies 9
Patent Ductus Arteriosus Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
Patent Ductus Arteriosus Therapeutics – Products under Development by Companies 15
Patent Ductus Arteriosus Therapeutics – Products under Investigation by Universities/Institutes 16
Companies Involved in Patent Ductus Arteriosus Therapeutics Development 17
PLx Pharma Inc. 17
Patent Ductus Arteriosus – Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Drug Profiles 23
PL 4500 Indomethacin-PC - Drug Profile 23
Product Description 23
Mechanism of Action 23

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012

Kawasaki Disease – Pipeline Review, H1 2012

Retinopathy – Pipeline Review, H1 2012

Patent Ductus Arteriosus – Pipeline Review, H1 2012

Yellow Fever – Pipeline Review, H1 2012

Cat Allergy – Pipeline Review, H1 2012

Lymphangioleiomyomatosis – Pipeline Review, H1 2012

Cholera – Pipeline Review, H1 2012

NeuroVive Pharmaceutical AB – Product Pipeline Review – 2012

Abiogen Pharma S.p.A. – Product Pipeline Review – 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Aarkstore.com
Scoop.it!

2012 || Pharmaceuticals || Kawasaki Disease – Pipeline Review, H1 2012 || Aarkstore.com

2012 || Pharmaceuticals || Kawasaki Disease – Pipeline Review, H1 2012 || Aarkstore.com | Aarkstore Enterprise-Oil and Gas Storage Industry to 2015 - Cost Reduction | Scoop.it

Global Markets Direct’s, Kawasaki Disease - Pipeline Review, H1 2012, provides
an overview of the Kawasaki Disease therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:


Kawasaki Disease – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Kawasaki-Disease-Pipeline-Review-H1-2012-215255.html

RSS link of Global Markets Direct 
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml

Summary

Global Markets Direct’s, Kawasaki Disease - Pipeline Review, H1 2012, provides an overview of the Kawasaki Disease therapeutic pipeline. This report provides information on the therapeutic development for Kawasaki Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Kawasaki Disease. Kawasaki Disease - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Kawasaki Disease.
- A review of the Kawasaki Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Kawasaki Disease Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Kawasaki Disease 7
Kawasaki Disease Therapeutics under Investigation by Universities/Institutes 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Kawasaki Disease Therapeutics – Products under Investigation by Universities/Institutes 13
Kawasaki Disease – Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Combination Products 15
Assessment by Route of Administration 16
Assessment by Molecule Type 18
Drug Profiles 20
Remicade - Drug Profile 20
Product Description 20
Mechanism of Action 20
R;D Progress 20
Cyclosporine - Drug Profile 21
Product Description 21
Mechanism of Action 21
R;D Progress 21
Remicade + Immunoglobulin - Drug Profile 22

List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:

Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1



Corneal Neovascularization – Pipeline Review, H1 2012

Meningioma – Pipeline Review, H1 2012

Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012

Kawasaki Disease – Pipeline Review, H1 2012

Retinopathy – Pipeline Review, H1 2012

Patent Ductus Arteriosus – Pipeline Review, H1 2012

Yellow Fever – Pipeline Review, H1 2012

Cat Allergy – Pipeline Review, H1 2012

Lymphangioleiomyomatosis – Pipeline Review, H1 2012

Cholera – Pipeline Review, H1 2012

NeuroVive Pharmaceutical AB – Product Pipeline Review – 2012

Abiogen Pharma S.p.A. – Product Pipeline Review – 2012



 

 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on sample@aarkstore.com





For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.